The U.S. FDA and Health Canada will be co-hosting a regional public consultation on Wednesday, May 11, 2022 from 1:00pm-4:00pm EDT to provide information and receive comments on current ICH working group activities and anticipated future topics. The purpose of the public meeting is to solicit input prior to the next International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) biannual Assembly and Management Committee meetings scheduled in May 2022. Links to the meeting registration and agenda have been posted on the ICH website.
For more information about ICH, please visit the ICH page on Canada.ca or contact the ICH coordinator inbox at ich@hc-sc.gc.ca.
